Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S412000, C514S414000, C546S199000, C548S360500, C548S453000, C548S518000
Reexamination Certificate
active
11433171
ABSTRACT:
Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
REFERENCES:
patent: 3340269 (1967-09-01), Blatter
patent: 3365459 (1968-01-01), Blatter
patent: 5508300 (1996-04-01), Duplantier
patent: WO 9501980 (1994-06-01), None
Barth et al. “The Development of Cannabinoid Antagonists” Current Medicinal Chemistry 1999, vol. 6, pp. 745-755.
McMurry, John “Organic Chemistry—Fourth Edition” Brooks/Cole Publishing Company, 1996, pp. 946-947.
Patani and LaVoie “Bioisosterism: A Rational Approach in Drug Design” Chem. Rev. 1996, 3147-3176.
Barth, F., et al.,Current Medicinal Chemistry,“The Development of Cannabinoid Antagonists”, vol. 6, pp. 748-755 (1999).
Duplantier, A., et al.,J. Med. Chem,“7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil Phosphodlesterase”, vol. 41, pp. 2268-2277 (1998).
Muccioli, et al.,Current Medicinal Chemistry,“Current Knowledge on the Antagonists and Inverse Agonists of Cannabinoid Receptors”, vol. 12, pp. 1361-1394 (2005).
Smith, et al.,JDRUGS, “Recent Advances in the Research and Development of CB1 Antagonists”, vol. 8(1) pp. 53-66 (2005).
Carpino Philip A.
Dow Robert L.
Benson Gregg C.
Kosack Joseph R.
McKane Joseph K.
Musser Arlene K.
Pfizer Inc
LandOfFree
Cannabinoid receptor ligands and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cannabinoid receptor ligands and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannabinoid receptor ligands and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865284